These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9713875)

  • 41. Inhibitors of oxalocalcic lithiasis: effects of their interactions on calcium oxalate crystallization.
    Muñoz JA; López-Mesas M; Valiente M
    Urology; 2012 Nov; 80(5):1163.e13-8. PubMed ID: 22748613
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of sodium citrate, potassium citrate, and citric acid in preventing experimental calcium oxalate urolithiasis in rats.
    Ogawa Y; Tanaka T; Yamaguchi K; Morozumi M; Kitagawa R
    Hinyokika Kiyo; 1987 Nov; 33(11):1772-7. PubMed ID: 3445859
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of drugs on crystal adhesion to injured urothelium.
    Pantazopoulos D; Karagiannakos P; Sofras F; Kostakopoulos A; Deliveliotis C; Dimopoulos C
    Urology; 1990 Sep; 36(3):255-9. PubMed ID: 1697434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial.
    Allie-Hamdulay S; Rodgers AL
    Urol Res; 2005 May; 33(2):116-24. PubMed ID: 15871014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A simple method for quantitating the propensity for calcium oxalate crystallization in urine.
    Wabner CL; Pak CY
    J Lithotr Stone Dis; 1991 Jul; 3(3):255-9. PubMed ID: 11536933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of renal calcium stone disease with the synthetic glycosaminoglycan pentosan polysulphate.
    Fellström B; Backman U; Danielson B; Wikström B
    World J Urol; 1994; 12(1):52-4. PubMed ID: 7516780
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Binding of glycosaminoglycan inhibitors to calcium oxalate crystals in relation to ionic strength.
    Fellström B; Lindsjö M; Danielson BG; Karlsson FA; Ljunghall S
    Clin Chim Acta; 1989 Apr; 180(3):213-220. PubMed ID: 2472910
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients.
    Baxmann AC; De O G Mendonça C; Heilberg IP
    Kidney Int; 2003 Mar; 63(3):1066-71. PubMed ID: 12631089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of sodium pentosan polysulphate on the thrombogenicity of prothrombin complex concentrates.
    Klöcking HP; Dornheim G; Schulze-Riewald H
    Thromb Res; 1992 Jul; 67(1):41-8. PubMed ID: 1279834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biological control to diminish dangers of urolithiasis.
    Sarig S; Azoury R; Garti N
    Urol Int; 1985; 40(5):274-6. PubMed ID: 2866620
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Study of spontaneous crystalluria in patients with calcium oxalate calculi].
    Nguyen HV; Daudon M; Réveillaud RJ; Jungers P
    Nephrologie; 1987; 8(2):65-9. PubMed ID: 3614507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pentosan polysulphate and glycosaminoglycan polysulphate stimulate the synthesis of hyaluronan in vivo.
    Francis DJ; Hutadilok N; Kongtawelert P; Ghosh P
    Rheumatol Int; 1993; 13(2):61-4. PubMed ID: 7689248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of anti-urolithiatic and diuretic activities of watermelon (Citrullus lanatus) using in vivo and in vitro experiments.
    Siddiqui WA; Shahzad M; Shabbir A; Ahmad A
    Biomed Pharmacother; 2018 Jan; 97():1212-1221. PubMed ID: 29145146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of lupeol, a pentacyclic triterpene, on urinary enzymes in hyperoxaluric rats.
    Malini MM; Baskar R; Varalakshmi P
    Jpn J Med Sci Biol; 1995; 48(5-6):211-20. PubMed ID: 8718554
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.
    Laube N; Hergarten S; Hoppe B; Schmidt M; Hesse A
    J Urol; 2004 Jul; 172(1):355-9. PubMed ID: 15201810
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
    Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.